LTRN
Lantern Pharma Inc.Company Information
- Company Name
- Lantern Pharma Inc.
- CIK
- CIK0001763950
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- LTRN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- LTRN
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-12
- Last sale
- 2025-06-13
- Shares purchased (TTM)
- 97,088
- Shares sold (TTM)
- 241,694
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,882,855
- Shares outstanding
- 12,423,174
- Ownership
- 23.21%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -28.11%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 7 | 5 | 4 | 8 | 6 | 6 | 8 | 8 | 13 | 18 | 22 | 26 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 8 | 7 | 11 | 13 | 17 | 21 | 25 | 30 | 35 | 39 | 43 | 47 | ||||||
| Marketable Securities Current | 1 | 1 | 6 | 4 | 10 | 13 | 17 | 20 | 20 | 20 | 19 | 19 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 3 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Costs | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 9 | 7 | 11 | 14 | 17 | 21 | 26 | 30 | 36 | 40 | 44 | 48 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 5 | 4 | 3 | 2 | ||||||
| Accounts Payable And Accrued Liabilities Current | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 4 | 3 | 2 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Noncurrent | 7 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 12 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 5 | 4 | 3 | 2 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 100 | 100 | 100 | 99 | 97 | 97 | 97 | 97 | 97 | 96 | 96 | 97 | ||||||
| Stockholders Equity | -3 | 3 | 7 | 10 | 13 | 17 | 21 | 27 | 31 | 36 | 41 | 45 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -104 | -96 | -93 | -89 | -85 | -81 | -76 | -70 | -66 | -61 | -55 | -51 | ||||||
| Liabilities And Stockholders Equity | 9 | 7 | 11 | 14 | 17 | 21 | 26 | 30 | 36 | 40 | 44 | 48 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Issued | 13 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | ||||||
| Shares Outstanding | 13 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLantern Pharma Inc. (LTRN) — SEC Financial Statements & Analysis
Lantern Pharma Inc. (LTRN) is a pharmaceutical preparations company, incorporated in TX. Lantern Pharma Inc. trades on Nasdaq as: LTRN. Lantern Pharma Inc. (LTRN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Lantern Pharma Inc. carries a market cap of $51.80M, a P/E ratio of -2.78x, a P/B ratio of -16.10x, an enterprise value of $45.14M, and an EV/EBITDA multiple of -2.92x. On profitability, it posts a Return on Equity (ROE) of -400.92%, a Return on Assets (ROA) of -143.36%, and a Return on Invested Capital (ROIC) of -227.75%. Per share, it reports EPS of $-1.50, diluted EPS of $-1.50, free cash flow per share of $-1.13, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -3.10% year-over-year and EPS growth of -15.88% year-over-year. On the balance sheet, it maintains a current ratio of 1.96x, a quick ratio of 1.70x, working capital of $4.14M, a debt-to-equity ratio of -3.67x, a debt ratio of 1.37, free cash flow of $-14.08M (TTM), and net debt of $-6.66M. Figures sourced from SEC EDGAR.
- Market Cap
- $51.80M
- P/E TTM
- -2.78x
- EPS TTM
- $-1.50
- P/B TTM
- -16.10x
- ROE TTM
- -400.92%
- ROA TTM
- -143.36%
- Debt To Equity
- -3.67x
- Free Cash Flow TTM
- $-14.08M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Lantern Pharma Inc. in?
Lantern Pharma Inc. (LTRN) operates in the Pharmaceutical Preparations industry.
What exchange does LTRN trade on?
Lantern Pharma Inc. (LTRN) trades on the Nasdaq.
Where is Lantern Pharma Inc. incorporated?
Lantern Pharma Inc. is incorporated in TX.
When was Lantern Pharma Inc. (LTRN)'s most recent SEC filing?
Lantern Pharma Inc. (LTRN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is LTRN's market cap?
Lantern Pharma Inc. (LTRN) has a market capitalization of $51.80M as of 2026-06-30.
What is LTRN's EPS (earnings per share)?
Lantern Pharma Inc. (LTRN)'s trailing twelve month EPS is $-1.50 as of 2026-06-30.
What is LTRN's ROE (return on equity)?
Lantern Pharma Inc. (LTRN)'s trailing twelve month Return on Equity (ROE) is -400.92% as of 2026-06-30.
What is LTRN's ROA (return on assets)?
Lantern Pharma Inc. (LTRN)'s trailing twelve month Return on Assets (ROA) is -143.36% as of 2026-06-30.
What is LTRN's ROIC (return on invested capital)?
Lantern Pharma Inc. (LTRN)'s trailing twelve month Return on Invested Capital (ROIC) is -227.75% as of 2025-12-31.
What is LTRN's EV/EBITDA?
Lantern Pharma Inc. (LTRN)'s trailing twelve month EV/EBITDA is -2.92x as of 2026-06-30.